Matthew Katz, Author at Radiation Nation

High Dose, HyTEC – Guidance for Stereotactic and Hypofractionated Radiation Treatment Planning

June 10, 2021 Matthew Katz

Radiation oncology always seeks to strike the right balance between cancer control and the risk of treatment toxicity. As our understanding and technological abilities have evolved, so too has the...

Rectal Cancer Practice Guidelines for Radiation Oncology

November 15, 2020 Matthew Katz

For our November #radonc #jc we will discuss the role of radiation therapy in management of rectal cancer. In the past 30 years, it has evolved from postoperative therapy to...

One and 80% done? Intraoperative radiation therapy as a partial breast irradiation technique for early stage breast cancer

September 13, 2020 Matthew Katz

For our September #radonc #jc we will be discussing partial breast irradiation (PBI), focusing on intraoperative radiation therapy (IORT) as part of breast conserving therapy. As the trend toward de-escalation...

Taking Cancer Research up a NOTCH

August 10, 2020 Matthew Katz

Usually, we discuss newly published cancer research for the journal club. Next weekend, we will discuss a new way for training physicians to organize and conduct research. What happens when...

Helping People with Cancer adjust to COVID-19

May 10, 2020 Matthew Katz

For #radonc journal club, we will discuss how people with cancer may need specific attention during the current pandemic. “Addressing the needs of cancer survivors during the COVID-19 pandemic” DOI: https://link.springer.com/article/10.1007/s11764-020-00884-w...

Guidelines for #radonc Journal Club in 2020

January 13, 2020 Matthew Katz

Bringing Back #radonc Journal Club on Twitter After a hiatus, we are excited to announce restarting #radonc journal club on Twitter! From 2014-2017, we had almost monthly discussions on cancer...

Postoperative Chemotherapy and Radiation in High-Risk Endometrial Cancer in PORTEC-3

March 12, 2018 Matthew Katz

After a hiatus, we are ready to return to #radonc journal club. For our March #radonc journal club we will discuss adjuvant chemoradiation in high-risk endometrial cancer. Our article from The Lancet Oncology is: Adjuvant...

Oncology Leadership and Industry Funding: How Often, and How Much?

October 14, 2017 Matthew Katz

For our October #radonc journal club we will discuss industry funding in U.S. radiation oncology and medical oncology leaders. Academic centers and departmental chairs often set the course for medical research and...

Chemoradiation for Limited Stage Small Cell Lung Cancer: Are You CONVERTed?

September 10, 2017 Matthew Katz

For our September #radonc journal club we will discuss twice-daily versus daily chemoradiation for limited stage small cell lung cancer (LS-SCLC). Twice-daily radiation has been controversial for some time –...

Matthew Katz

62 articles

Stay up to date